Journey Medical (DERM) Total Debt: 2020-2025
Historic Total Debt for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $25.2 million.
- Journey Medical's Total Debt rose 27.16% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.2 million, marking a year-over-year increase of 356.02%. This contributed to the annual value of $24.9 million for FY2024, which is 70.15% up from last year.
- According to the latest figures from Q3 2025, Journey Medical's Total Debt is $25.2 million, which was up 0.19% from $25.1 million recorded in Q2 2025.
- Journey Medical's 5-year Total Debt high stood at $25.2 million for Q3 2025, and its period low was $812,000 during Q4 2021.
- Moreover, its 3-year median value for Total Debt was $19.8 million (2023), whereas its average is $19.9 million.
- Its Total Debt has fluctuated over the past 5 years, first plummeted by 84.44% in 2021, then soared by 2,704.68% in 2022.
- Quarterly analysis of 5 years shows Journey Medical's Total Debt stood at $812,000 in 2021, then soared by 2,704.68% to $22.8 million in 2022, then plummeted by 35.80% to $14.6 million in 2023, then spiked by 70.15% to $24.9 million in 2024, then grew by 27.16% to $25.2 million in 2025.
- Its Total Debt was $25.2 million in Q3 2025, compared to $25.1 million in Q2 2025 and $25.0 million in Q1 2025.